CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionOperating margin is 42.6%, higher than 95% of its Medical Devices peers (median 8.1%)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
860.15BKRW609.02M · vs all stocks (USD)
Trailing P/E
158.78xvs Medical Devices peers
Revenue (TTM)
76.63BKRW54.26M · vs all stocks (USD)
Profit Margin
39.70%vs Medical Devices peers
Beta
0.1640xvs all stocks
52-Week Change
98.83%vs all stocks
Market Capitalization
860.15BKRW609.02M · vs all stocks (USD)
Enterprise Value
843.92BKRW597.53M · vs all stocks (USD)
Trailing P/E
158.78xvs Medical Devices peers
Forward P/E
10.02xvs Medical Devices peers
PEG Ratio
-0.0660xvs Medical Devices peers
Price to Sales (TTM)
11.22xvs Medical Devices peers
Price to Book (MRQ)
15.87xvs Medical Devices peers
Enterprise to Revenue
11.01xvs Medical Devices peers
Enterprise to EBITDA
26.21xvs Medical Devices peers
Gross Margin
64.12%vs Medical Devices peers
Profit Margin
39.70%vs Medical Devices peers
Operating Margin
42.59%vs Medical Devices peers
Return on Assets (TTM)
29.68%vs Medical Devices peers
Return on Equity (TTM)
80.37%vs Medical Devices peers
Revenue (TTM)
76.63BKRW54.26M · vs all stocks (USD)
Revenue per Share (TTM)
2.03KKRWUpdated Aug 19, 2026Quarterly Revenue Growth
699.60%vs Medical Devices peers
Gross Profit (TTM)
53.11BKRW37.60M · vs all stocks (USD)
EBITDA (TTM)
32.09BKRW22.72M · vs all stocks (USD)
Net Income (TTM)
30.42BKRW21.54M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
699.57%vs Medical Devices peers
Operating Cash Flow (TTM)
5.70BKRW4.04M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
16.09BKRW11.39M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
56.64MKRWFY2025 · Dec 31, 2025Revenue
48.17BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
13.29BKRWFY2025 · Dec 31, 2025Gross Profit
34.88BKRWFY2025 · Dec 31, 2025Operating Income
16.33BKRW11.56M · vs all stocks (USD)
Pre-tax Income
16.10BKRWFY2025 · Dec 31, 2025Income Tax Expense
58.49MKRWFY2025 · Dec 31, 2025Net Income
16.05BKRWFY2025 · Dec 31, 2025EBIT
16.34BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
17.65BKRWFY2025 · Dec 31, 2025Research & Development
4.56BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
5.55BKRWFY2025 · Dec 31, 2025Other Operating Expenses
277.64MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
235.62MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
238.00MKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
16.05BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
43.36MKRWFY2025 · Dec 31, 2025Operating Cash Flow
-3.80BKRWFY2025 · Dec 31, 2025Free Cash Flow
-5.27BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
11.10BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
16.05BKRWFY2025 · Dec 31, 2025Stock-based Compensation
1.31BKRWFY2025 · Dec 31, 2025Other Non-cash Items
2.39MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-17.87BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.28BKRWFY2025 · Dec 31, 2025Capital Expenditures
-1.48BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-156.05MKRWFY2025 · Dec 31, 2025Net Acquisitions
100.00MKRWFY2025 · Dec 31, 2025Purchase of Investments
0.00KRWFY2025 · Dec 31, 2025Other Investing Activity
-468.94MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.84BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-420.90MKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-420.90MKRWFY2025 · Dec 31, 2025Other Financing Charges
-10.00KRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-193.27MKRWFY2025 · Dec 31, 2025Shares Outstanding
38.06MSharesUpdated Aug 19, 2026Float Shares
25.17MSharesUpdated Aug 19, 2026% Held by Insiders
38.84%vs all stocks
% Held by Institutions
4.27%vs all stocks
Total Cash (MRQ)
14.33BKRW10.15M · vs all stocks (USD)
Total Cash per Share (MRQ)
376.64KRWUpdated Aug 19, 2026Total Debt (MRQ)
3.78BKRW2.67M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0697xvs Medical Devices peers
Current Ratio (MRQ)
3.79xvs Medical Devices peers
Book Value per Share (MRQ)
1.42KKRWUpdated Aug 19, 2026Total Assets
54.20BKRW38.38M · vs all stocks (USD)
Total Current Assets
40.44BKRWFY2025 · Dec 31, 2025Total Liabilities
14.58BKRWFY2025 · Dec 31, 2025Total Non-current Assets
13.76BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
3.78BKRWFY2025 · Dec 31, 2025Total Current Liabilities
10.80BKRWFY2025 · Dec 31, 2025Cash Equivalents
11.10BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
11.10BKRWFY2025 · Dec 31, 2025Accounts Receivable
22.01BKRWFY2025 · Dec 31, 2025Inventory
4.01BKRWFY2025 · Dec 31, 2025Accounts Payable
3.74BKRWFY2025 · Dec 31, 2025Short-term Debt
2.29BKRWFY2025 · Dec 31, 2025Other Current Liabilities
40.00KRWFY2025 · Dec 31, 2025Long-term Debt
1.52BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
10.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
6.33BKRWFY2025 · Dec 31, 2025Retained Earnings
-29.00BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
39.62BKRW28.05M · vs all stocks (USD)
52-Week Low
10.83KKRWUpdated Aug 19, 202652-Week High
64.20KKRWUpdated Aug 19, 202652-Week Change
98.83%vs all stocks
Beta
0.1640xvs all stocks
50-Day MA
29.75KKRWUpdated Aug 19, 2026200-Day MA
40.71KKRWUpdated Aug 19, 2026Avg 10-Day Volume
502.81KSharesUpdated Aug 19, 2026Avg 30-Day Volume
306.15KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
142.33KRWUpdated Aug 19, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 42.6%, higher than 95% of its Medical Devices peers (median 8.1%)Significant
Operating margin: 0.43Industry median: 0.08Industry P95: 0.34Peers compared: 102
Profit margin is 39.7%, higher than 95% of its Medical Devices peers (median 4.8%)Significant
Profit margin: 0.40Industry median: 0.05Industry P95: 0.32Peers compared: 102
Return on equity is 80.4%, higher than 95% of its Medical Devices peers (median 3%)Significant
Return on equity: 0.80Industry median: 0.03Industry P95: 0.17Peers compared: 102
Return on assets is 29.7%, higher than 95% of its Medical Devices peers (median 1.9%)Significant
Return on assets: 0.30Industry median: 0.02Industry P95: 0.12Peers compared: 102
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 21,542,035.751Operating Cash Flow (USD, TTM): 4,036,994.759
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Achieve Life Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jinhe Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
BrainsWay Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tectonic Therapeutic Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Bohui Innovation Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Allogene Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
KLA Corporation
5 interpretationsROE, ROA, And Operating ROA ElevatedDecline With Range Expansion And DrawdownIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated
Groupe Dynamite Inc.
5 interpretationsROE, ROA, And Operating ROA ElevatedDecline With Range Expansion And DrawdownIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated
Power Solutions International, Inc.
5 interpretationsMinimal Tax and Interest DragROE, ROA, And Operating ROA ElevatedDecline With Range Expansion And DrawdownIndustry-Benchmarked Return on Capital ElevatedThree Asset-Base Ratios Elevated